A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation
- 5 September 2013
- journal article
- Published by American Society of Hematology in Blood
- Vol. 122 (10), 1793-1801
- https://doi.org/10.1182/blood-2013-06-508952
Abstract
Hemolytic transfusion reactions (HTRs) due to incompatible red blood cell (RBC) transfusions are a leading cause of transfusion associated death. Although many transfused incompatible RBCs are cleared, some remain in circulation despite the presence of RBC-specific antibodies, potentially due to “antigen modulation.” With a goal of better understanding incompatible RBC clearance, we generated a murine model with RBC-specific expression of a clinically significant human antigen (KEL2) known to be involved in antigen modulation as well as in HTRs. Wild-type (WT) recipients transfused with transgenic KEL2 RBCs generated anti-KEL glycoprotein alloantibodies, which fixed complement, led to intravascular hemolysis, and resulted in decreased levels of KEL2 antigen detectable on cells remaining in circulation. Antigen modulation did not appear to solely reflect removal of RBCs with higher antigen expression, because cells continued to display antigen modulation in the absence of significant clearance. Recipients genetically lacking complement exhibited lesser degrees of incompatible RBC clearance and antigen modulation in comparison with WT or FcγR knock-out (KO) animals, suggesting a role for complement in RBC clearance. In summary, this HTR model may serve as a platform to test strategies to downmodulate antigen and inhibit incompatible RBC clearance, thus potentially mitigating transfusion dangers.Keywords
This publication has 36 references indexed in Scilit:
- Initiation and Regulation of Complement during Hemolytic Transfusion ReactionsClinical and Developmental Immunology, 2012
- Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cellsTransfusion, 2012
- An autoanti‐Kpb immunoglobulin M that simulates antigen suppressionTransfusion, 2009
- Identification of a complement receptor 1 peptide for inhibition of immune hemolysisBiochemical and Biophysical Research Communications, 2007
- ComplementNew England Journal of Medicine, 2001
- ComplementNew England Journal of Medicine, 2001
- The multifunctional role of C3, the third component of complementImmunology Today, 1988
- Measurement of the Third Component of Complement Bound to Red Blood Cells in Patients with the Cold Agglutinin SyndromeJCI Insight, 1973
- THE ROLE OF COMPLEMENT IN ANTIBODY‐MEDIATED RED‐CELL DESTRUCTIONBritish Journal of Haematology, 1970
- Isoantibody-Induced Cellular Resistance to Immune Hæmolysis in vivo and in vitroNature, 1964